Prev：Genetically engineered MSCs overexpressing hepatocyte growth factor for the treatment of human refractory wounds.(KTA0002-21.1)
Next：Genetically engineered nanovesicles based anti-EphA2/CD3 bispecific antibody promotes T cell immune response for triple negative breast cancer treatment(KTB1420-13.2)
